Mutations in coagulation factors in women with unexplained late fetal loss

New England Journal of Medicine

Volumn 343, Issue 14, 2000, Pages 1015-1018

  Martinelli, Ida ^a,c   Taioli, Emanuela ^a   Cetin, Irene ^b   Marinoni, Alessandra ^a   Gerosa, Sonia ^a   Villa, Maria V ^c   Bozzo, Maddalena ^b   Mannucci, Pier M ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b SAN PAOLO HOSPITAL   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ADULT; ARTICLE; BLOOD CLOTTING DISORDER; CONTROLLED STUDY; FEMALE; FETUS WASTAGE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL ANALYSIS; VEIN THROMBOSIS;

ABORTION, SPONTANEOUS; ADULT; CASE-CONTROL STUDIES; FACTOR V; FEMALE; HETEROZYGOTE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREVALENCE; PROTHROMBIN; RISK;

EID: 0034610031     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200010053431405     Document Type: Article

References (33)

1. Recurrent miscarriage. I. Definition and epidemiology
2. Recurrent stillbirth: Significance and characteristics
3. Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent - The nimes obstetricians and haematologists study5 (NOHA5)
4. The importance of primary diagnosis in perinatal death
5. Pregnancy loss in the antiphospholipid-antibody syndrome - A possible thrombogenic mechanism
6. High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and anti-phospholipid antibodies
7. Antiphospholipid antibodies and fetal death
8. Autoimmune causes of recurrent pregnancy loss
9. The risk of abortion and stillbirth in antithrombin-, protein C-, and protein S-deficient women
10. Increased fetal loss in women with heritable thrombophilia
11. Deep-vein thrombosis
12. Risk factors for venous thrombotic disease
13. Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction
14. Factor V Leiden mutation as a risk factor for recurrent pregnancy loss
15. Factor V Leiden is associated with repeated and recurrent unexplained fetal losses
16. The risk of fetal loss in family members of probands with factor V Leiden mutation
17. Increased risk for fetal loss in carriers of factor V Leiden mutation
18. Increased frequency of genetic thrombophilia in women with complications of pregnancy
19. Hyperhomocysteinemia, atherosclerosis and thrombosis
20. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies
21. Thrombophilia and fetal loss
22. The population genetics of factor V Leiden
23. Geographic distribution of the 20210 G to A prothrombin variant
24. Mutation in blood coagulation factor V associated with resistance to activated protein C
25. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
26. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
27. Criteria for the diagnosis of lupus anticoagulants: An update
28. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilla: A study of 150 families
29. Predicting preeclampsia
30. Delayed childbearing
31. Clinical and pathologic correlates of stillbirths in a single institution
32. Differences in late fetal death rates in association with determinants of small for gestational age fetuses: Population based cohort study
33. Safety of low-molecular-weight heparin in pregnancy: A systematic review